Previous studies showed that acute administration of noncholinergjc doses of malathion increased macrophage function and the generation of a primary humoral immune response to a T-dependent antigen and caused mast cell degranulation. Recent studies using mast cell-deficient mice showed that the presence of mast cells was necessary for the increase in macrophage function observed after oral administration of malathion, and reconstitution with bone marrow-derived mast cells restored the ability of malathion to increase macrophage function. In the present study, the contribution of mast cell mediators to alterations in macrophage function after oral administration of malathion was examined. Controls in this study included the effect of the agent to be examined on resident peritoneal macrophages and macrophages elicited with pristane, an agent that can stimulate macrophages in the absence of mast cells. Coadministration of intraperitoneal cromolyn, a stabilizer of mast cell membranes, with oral malathion blocked the ability of malathion to increase macrophage function as measured by the generation of respiratory burst activity, the phagocytosis of opsonized yeast, and the production of cathepsin D. On the other hand, administration of cromolyn to mice whose macrophage function was stimulated with pristane did not affect the observed increases in macrophage function. As oral administration of malathion caused histamine release, the ability of a histamine receptor antagonist, pyrilamine, to alter the response of peritoneal macrophages to oral administration of malathion was also examined. Intraperitoneal administration of pyrilamine partially blocked the effects of oral administration of malathion on peritoneal macrophage function, but did not affect the function of resident or pristane-elicited peritoneal macrophages. These data suggest that mediators from mast cells contribute to the elevation in macrophage function observed after oral malathion administration. C 1996 Society of Toxicology Malathion is an organophosphate pesticide which has a low mammalian toxicity due to detoxification of malathion 1 Supported by USPHS Grant ES-04337. 2 To whom correspondence should be addressed into nontoxic derivatives by carboxy esterases (Aldridge el al, 1979; Dauterman, 1971; Frawley et al, 1957; March et al, 1956; Umetsu et al, 1977 Umetsu et al, , 1981 . Because of this low toxicity, malathion is used in situations where large urban populations and domesticated animals may be exposed (Weeks etal, 1977) . Such situations include mosquito eradication, spraying of tobacco plants, and aerial spraying for the eradication of fruit flies in citrus-producing states; however, very little is known with respect to the effects of malathion exposure on the human immune system. In 1964, one study was published in which 43% of persons dermally exposed to malathion under an occlusive patch had symptoms of contact dermatitis on reexposure (Milby and Epstein, 1964) .
Animal studies have shown that acute administration of noncholinergic doses of purified malathion elevated the humoral immune and proliferative response to stimuli (Rodgers et al, 1986; Rodgers and Ellefson, 1990) . Further studies showed that the stimulation of the proliferative responses to mitogen by malathion was due to alterations in the adherent cell population (Rodgers and Ellefson, 1990) . Further studies indicated that in vivo administration or in vitro exposure to metabolized malathion increased the respiratory burst activity of peritoneal macrophages (Rodgers and Ellefson, 1990) . More recently, it was shown that oral administration of very low doses of malathion increases macrophage function as measured by respiratory burst activity and phagocytosis (Rodgers and Ellefson, 1992) . These studies also showed that in vivo administration of malathion leads to degranulation of peritoneal mast cells. Further, in vitro exposure of purified mast cells or a basophilic tumor line to metabolites of malathion resulted in the release of mast cell mediators, suggesting that malathion, particularly metabolized malathion, can cause the degranulation of basophilic cells (Xiong and Rodgers, submitted) . Most recently, studies involving mast cell-deficient mice showed that the presence of mast cells was necessary for an elevation in macrophage function after malathion administration (Rodgers et al, 1996) .
Published reports indicate that mast cell mediators, which include cytokines, lipid-derived mediators, histamine. hepa- 
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FIG. 1. Effect of disodium cromoglycate (DSCG) on macrophage respiratory burst activity. Peritoneal macrophages were harvested after coadministration of intrapentoneal cromolyn and oral malathion, and the respiratory burst activity was assessed by producuon of hydrogen peroxide. The following groups were tested: (1) naive control; (2) vehicle control; (3) intrapentoneal administration of cromolyn (DSCG) to naive animals; (4) oral administration of malathion and intrapentoneal administration of cromolyn; (5) oral administration of malathion; (6) intrapentoneal injection of pristane and cromolyn; and (7) intrapentoneal injection of pristane. Statistical analysis (p < 0.05) indicated that groups 5, 6, and 7 are elevated compared with controls and group 4 is lower than group 5. These data are the means and standard errors of nine animals per group (three cxpenments with three mice per group in each experiment) rin, proteases, and proteoglycans, can modulate macrophage function (Yoffee et ai, 1985; Bonavida et ai, 1990; Jaques, 1979) . Published studies showed that macrophages can ingest mast cell granules after degranulation (Baggiolini et ai, 1982; Lindahl el ai, 1979; Rodgers and Ellefson, 1992) . Further studies have shown that macrophages express histamine receptors and expression of these receptors is modulated by macrophage differentiation (Feder et ai, 1991; Gespach et ai, 1986) . Mouse macrophages have also been shown to express heparin receptors. In addition, heparin and other polyanions were also shown to stimulate macrophage function and increase the production of inflammatory mediators by mononuclear cells (Yoffee et ai, 1985; Bleiberg et ai, 1983; Schultz et ai, 1977; Jaques, 1979) . Therefore, studies were conducted to determine if the release of mast cell mediators, specifically histamine, was required for the expression of the alterations in macrophage function observed after administration of noncholinergic doses of malathion.
MATERIALS AND METHODS
Mice. Female C57BL/6 mice, 6 to 8 weeks old, were purchased from Battin and Kingman (Gilroy, CA) and quarantined at least 7 days prior to use. In the studies to determine which stimuli could elicit and stimulate macrophages in the absence of mast cells, WBB6FI-WAVv mice from Jackson Laboratones were used (Galli and Kitamura, 1987) . The animals were housed on a 12-hr light:dark cycle and food and water were available ad libitum. The malathion was administered in corn oil via oral gavage at noncholinergic doses (450-600 mg/kg) 18 hr prior to sacrifice. The blocking agents were administered via intrapentoneal injection at the following doses and times relative to malathion administration: (1) cromolyn 100 mg/kg, coadministered with malathion; (2) pyrilamine 3 mg/kg, coadministered with malathion. To mice that receive pristane, 1 ml was injected intraperitoneally 4 days before sacrifice.
Macrophage respiratory burst function.
The respiratory burst system was assessed by the measurement of hydrogen peroxide production after stimulation with phorbol ester was conducted as previously described (Rodgers and Ellefson, 1992; Rodgers, 1995) . Briefly, murine peritoneal cells were harvested, the viability was assessed by trypan blue exclusion, and the cells were resuspended at 2 X 10* cells/ml in phosphate-buffered saline (PBS, pH 7.4). Aliquots, 100 //I, of cell suspension were added into wells nalva control vehicle control malathion + PYM malathion pristane + PYM pristene
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FIG.
2. Effect of pynlamine (PYM) on macrophage respiratory burst activity. Peritoneal macrophages were harvested after coadmimstration of intraperitoneal pyrilamine and oral malathion, and the respiratory burst activity was assessed by production of hydrogen peroxide. The following groups were tested: (1) naive control; (2) vehicle control; (3) intraperitoneal administration of pyrilamine to naive animals; (4) oral administration of malathion and intraperitoneal administration of pyrilamine; (5) oral administration of malathion; (6) intraperitoneal injection of pristane and pyrilamine; and (7) intraperitoneal injection of pristane. Statistical analysis (p < 0.05) indicated that groups 5, 6, and 7 are elevated compared with controls and group 4 is lower than group 5. These data are the means and standard errors of nine animals per group (three experiments with three mice per group in each experiment).
of a 96-well microtiter plate (Falcon). After a 1-hr incubation, cells were washed two times to remove nonadherent cells. Ninety microliters of PBS with 2,7-dichlorofluoroscein diacetate (DcFD, 5 /iM final concentration, Kodak Chemicals, Rochester, NY) was added into each well and incubated for 15 min An aliquot, 10 /il, of PMA (100 ng/ml, Sigma, St. Louis, MO) was added into each well to stimulate hydrogen peroxide production. The increase in fluorescent product was measured after a 1-hr incubation at 37°C on a Millipore Fluorescence Measurement System (Cytofluor 2350; excitation 505 nm, emission 530 nm). The intensity of the fluorescent product, 2,7-dichlorofluoroscein, was compared with that of a standard (Polysciences, Warnngton, PA).
Phagocytosis assay. Assessment of the phagocytic capability was conducted as previously described (Rodgers el a 1, 1985 (Rodgers el a 1, , 1986 . Yeast particles (Sigma) were hydrated in PBS and boiled for 1 hrto inactivate the particles. The inactivated particles were then opsonized by mixing 2x10' yeast particles/ml with heat-inactivated serum. After 1 hr, the particles were washed with PBS to remove excess serum proteins. To adhere the peritoneal cells for the measurement of phagocytic capability, 2 X 10 6 mononuclear cells in 1 ml were aliquoted onto a coverslip that has been placed in a 35-mm tissue culture dish. This was placed in a humidified environment of 5% CO 2 in air at 37°C for 2 hr At the end of this incubation, the coverslip was washed six times with PBS to remove nonadherent cells. After each rinse, one end of the coverslip was blotted with an absorbent towel to remove loosely associated liquid. An aliquot, 100 ^tl, of opsonized yeast was then added to the adherent peritoneal cells and incubated for 20 min longer. The coverslips were then washed three to six times. The coverslip was placed cell side down on the microscope slide. The number of yeast ingested per macrophage was determined for 100 to 200 cells per coverslip.
Cathepsin D production. Peritoneal macrophages, 10 X 10 7 cells/ ml, were lysed in PBS, 0.3% BSA. 0.1% Triton X-100 and centnfuged at I0,000g for 1 min (Diment el al., 1988, Rodriguez and Diment, 1992) . The level of cathepsin D in the supernatants was then determined. An aliquot, 5 ^il of sample, was placed in each of four microfuge tubes containing 20 /il of water (two tubes) or pepstatin A (10 fig/ml in DMSO, an inhibitor of cathepsin D, two tubes). An additional two tubes with 25 fi\ of water acted as blanks. The microfuge tubes were warmed to 37°C in a water bath and 25 jil of substrate (0.2 M sodium acetate buffer, pH 4.5, containing 2% hemoglobin, 0.2 M KC1, 0.1% Triton X-100) was added to each tube. The reaction between the enzyme and substrate was allowed to continue at 37°C for 60 min. After this time, 100 M' °f ice-cold 5% trichloroacetic acid was added to each 
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FIG.
3. Effect of disodium cromoglycate (DSCG, cromolyn) on phagocytic activity. Peritoneal macrophages were harvested after coadmimstration of intraperitoneal cromolyn and oral malathion, and the phagocytic activity was assessed by ingestion of opsonized yeast. The groups were tested as in Fig. 1 . Statistical analysis (p < 0.05.) indicated that groups 5, 6, and 7 are elevated compared with controls and group 4 is lower than group 5. These data are the means and standard errors of nine animals per group (three experiments with three mice per group in each experiment).
tube. Thereafter, the tubes were placed on ice for 5 min. The tubes were then centnfuged at 10,000g for 1 min. An aliquot, 100 /xl, of the supernatant was taken from each tube and placed with 100 p\ of ninhydnn into a glass tube The glass tubes were then boiled for 10 min and 1 ml water was added to each tube. An aliquot, 200 fi\, of each supernatant was then placed in wells of a 96-well microtiter plate at read at 550 nm.
Statistics.
The results are represented as the means and standard deviations of the data from nine mice (from three separate experiments) per group. The data were analyzed by analysis of variance followed by Student's I test. A p value less than 0.05 was considered significant.
RESULTS
Identification of Stimuli to Elicit Macrophages in Absence of Mast Cells
To interpret the studies outlined below properly, a control was needed in which macrophages could be stimulated without the involvement of mast cells. This control would allow for the determination of the effects of the inhibitory agent to be tested alone on stimulated macrophages. To determine which agents commonly used to stimulate or activate macrophages could do so in the absence of mast cells, the effect of intraperitoneal injection of thioglycollate or pristane on the activity of peritoneal macrophages from mast cell-deficient mice (WBBFl-WAVv) and their wild-type littermates was determined. The stimulation of macrophage function, as determined by respiratory burst activity and phagocytosis of opsonized yeast, by thioglycollate and pristane occurred to a similar extent in both strains of mice tested (data not shown). As pristane gave the most consistent stimulation of all functions tested, animals injected with pristane were used as a control for the effect of the cromolyn and pyrilamine on stimulated macrophage function in the studies below.
Respiratory Burst Function
The effect of coadministration of intraperitoneal cromolyn (Fig. 1) or pyrilamine (Fig. 2) with oral administration of malathion on the respiratory burst of peritoneal macro- phages, as measured by hydrogen peroxide production, was assessed. The following groups (the same in all figures) were tested: (1) naive control; (2) vehicle control; (3) intraperitoneal administration of the agent to be tested to naive animals; (4) oral administration of malathion and intraperitoneal administration of agent; (5) oral administration of malathion; (6) intraperitoneal injection of pristane and the agent to be tested; and (7) intraperitoneal injection of pristane. In Fig. 1 , the respiratory burst activity of the peritoneal macrophages harvested from mice that received oral administration of malathion, coadministration of pristane with disodium cromoglycate, or pristane alone were elevated compared with that of controls (naive, vehicle, and cromolyn alone). In addition, the group in which cromolyn was coadministered with malathion was reduced compared with the group that received malathion alone, but not different from the control groups. Similar observations were noted in the groups treated with pyrilamine. a histamine receptor antagonist (Fig. 2) .
Phagocytic Capability
The effect of disodium cromoglycate and pyrilamine on the mean number of yeast ingested per peritoneal macrophage was also measured (Figs. 3 and 4 ). The groups were tested were as listed above. As before, the phagocytic activity of the peritoneal macrophages harvested from mice that received oral administration of malathion, coadministration of pristane with disodium cromoglycate, or pristane alone were elevated compared with controls (naive, vehicle, and cromolyn alone; Fig. 3 ). In addition, the group in which cromolyn was coadministered with malathion was reduced compared with the group that received malathion alone, but not different from the control groups. Similar observations were noted in the groups treated with pyrilamine (Fig. 4) , with the exception of the group treated with malathion and pyrilamine. In this group, the phagocytic activity was not significantly reduced compared with the group that received malathion only. For this macrophage function and inhibitory 
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RG. 5. Effect of disodium cromoglycate (DSCG, cromolyn) on the production of cathepsin D. Peritoneal macrophages were harvested after coadministration of intraperitoneal cromolyn and oral malathion and the level of cathepsin D activity was assessed. The groups were tested as in Fig. 1 . Statistical analysis (p < 0.05) indicated that groups 5, 6, and 7 are elevated compared with controls and group 4 is lower than group 5. These data are the means and standard errors of nine animals per group (three experiments with three mice per group in each experiment). agent (but not for all other results presented), there was some variability between experiments (three experiments conducted) regarding the effect of pyrilamine on cells from naive mice. The results shown are the means of the data from all three studies. In two studies, but not the third, pyrilamine increased the phagocytic capability of the cells from naive mice.
Cathepsin D Production
The effect of disodium cromoglycate and pyrilamine on the production of Cathepsin D by peritoneal macrophage was also assessed (Figs. 5 and 6 ). The groups tested were as listed above. As with the two previous parameters of macrophage function, the production of cathepsin D by the peritonea] macrophages harvested from mice that received oral administration of malathion, coadministration of pristane with disodium cromoglycate, or pristane alone was elevated compared with controls (naive, vehicle, and cromolyn alone; Fig. 5 ). In addition, the group in which cromolyn was coadministered with malathion was reduced compared with the group that received malathion alone, but not different from the control groups. Similar observations were noted in the groups treated with pyrilamine (Fig. 6) .
DISCUSSION
Several studies have indicated that administration of noncholinergic doses of malathion will modulate macrophage function (Rodgers and Ellefson, 1990; . Further studies showed that oral administration of malathion leads to degranulation of peritoneal mast cells (Rodgers and Ellefson, 1992) . In addition, oral administration of malathion or in vitro exposure of basophilic cells to metabolites of malathion resulted in the release of mast cell mediators, including /?-hexosaminidase and histamine (Xiong and Rodgers, submitted) . Most recently, studies involving mast cell-deficient mice showed that the presence of mast cells was necessary for an elevation in macrophage function after malathion administration (Rodgers et ai, 1996) . Studies presented in this paper show that coadministration of a stabilizer of mast cell membranes that prevents degranulation, disodium cromoglycate (cromolyn), or an antagonist of the H r histamine receptor, pyrilamine, with malathion blocked the effects of malathion on most macrophage function with no effect on resident or pristaneelicited macrophages. Pyrilamine did not affect the phagocytic capability of macrophages from malathion-treated mice. The reason for the discrepancy between phagocytosis and the other functional parameters examined is unknown at this time. These data provide further evidence that the stimulation of macrophage function after oral administration of malathion is the result of alterations in mast cell exocytosis pathways.
The macrophage functions shown to be altered by malathion exposure were respiratory burst capacity, phagocytic capability, and level of cathepsin D. The production of hydrogen peroxide, as are all the parameters assessed in this report, by peritoneal macrophages is increased after macrophage stimulation (Rodgers, 1995) . The oxygen radicals that are produced via this system are involved in the microbicidal/tumoricidal activities of these cells; however, excessive production of these molecules can lead to tissue destruction and some have implicated them in mutagenesis. Phagocytosis is one of the means by which macrophages clear foreign invaders, such as bacteria, from the host. It is also a mechanism by which antigen uptake prior to processing for presentation in the generation of an immune response can occur (Rodgers et ai, 1985) . Lastly, cathepsin D is an an enzyme produced by macrophages and is involved in antigen processing for presentation (Rodriguez and Diment, 1992) . In summary, an increase in these macrophage functions after exposure to malathion may contribute to increased microbicidal or antigen presentation activities.
Published reports indicate that mast cell mediators, which include cytokines, lipid-derived mediators, histamine, heparin, proteases, and proteoglycans, can modulate macrophage function (Yoffee et ai, 1985; Jaques, 1979; Schultz et ai, 1977; Klein et ai, 1989; Bonavida et ai, 1990) . Cromolyn is a mast cell stabilizer used in many studies to assess the role of mast cell secretory products in the genesis of inflammation and disease processes (Klein et ai, 1989; Hinson et ai, 1989) . The interactions between mast cell mediators and macrophages after administration of malathion were confirmed by the ability of cromolyn to block the effects of malathion on peritoneal macrophages (Figs. 1, 3 , and 5).
Histamine is the major biogenic amine in basophilic cells (Bauza and Lagunoff, 1981) . It is stored in secretory granules at acidic pH (Lagunoff et al., 1985) . Histamine has a potent vasoactive and smooth muscle spasmogenic effects. In addition, histamine has been shown to affect macrophage function (Sternberg et al., 1987; Okamoto et al., 1990; Ohno et al., 1991; Feder et al., 1991) . Further studies showed that macrophages express H,-histamine receptors and expression of these receptors is modulated by macrophage differentiation (Gespach et al., 1986) . Pyrilamine is an H,-receptor antagonist that blocks the effects of histamine on macrophages and smooth muscle cells (Gespach et al., 1986; Robertson and Greaves, 1978) . In this study, coadministration of pyrilamine with malathion blocked the effects of malathion, but not pristane, on macrophage function as measured by respiratory burst activity and the production of cathepsin D (Figs. 2 and 6) ; however, the increase in phagocytosis observed was not reduced by pyrilamine administration (Fig.  4) . The reason for this differential between various macrophage functions with respect to antagonism of histamine is unknown at this time. These data suggest that one mediator that is involved in the activation of peritoneal mast cells after malathion administration is histamine.
In summary, malathion may stimulate macrophage function through the release of mast cell mediators and, more specifically, histamine.
